• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[接受放疗和化疗的食管癌5年生存者分析]

[Analysis of 5-year survivors of esophageal cancer treated with radiation and chemotherapy].

作者信息

Ohtake S, Asakawa H, Koyama K, Otawa H

出版信息

Gan No Rinsho. 1987 Mar;33(3):253-7.

PMID:2438435
Abstract

From 1967 to 1980, 240 cases of esophageal cancer, consisting of 153 curative and 87 palliative cases, were treated with a combination of radiation and chemotherapy. The five-year survival rate in 124 curative cases given a dose of more than 50 Gy was 12.9%, and 17 cases survived more than 5 years. In the 5-year survivors, T1 in the advancement of tumors, less than 7 cm in length, and cancer of both the serrated and tumorous types were characteristic factors, indicating a good prognosis. These cases were irradiated with a dose of 60-70 Gy and the tumors showed a high response to irradiation.

摘要

1967年至1980年期间,对240例食管癌患者进行了放疗和化疗联合治疗,其中包括153例根治性病例和87例姑息性病例。124例接受超过50 Gy剂量治疗的根治性病例的五年生存率为12.9%,有17例存活超过5年。在5年存活者中,肿瘤进展为T1期、长度小于7 cm以及锯齿状和肿瘤型癌症是预后良好的特征因素。这些病例接受了60 - 70 Gy的照射,肿瘤对放疗显示出高度反应。

相似文献

1
[Analysis of 5-year survivors of esophageal cancer treated with radiation and chemotherapy].[接受放疗和化疗的食管癌5年生存者分析]
Gan No Rinsho. 1987 Mar;33(3):253-7.
2
[Combined treatment of esophageal cancer with radiation and bleomycin. Part VI. Long-term results and 3-year survivors].[食管癌放疗与博来霉素联合治疗。第六部分。长期结果及3年生存者]
Gan To Kagaku Ryoho. 1984 Jan;11(1):117-22.
3
[Radiotherapy of inoperable esophageal cancer. Retrospective analysis apropos of 108 cases].[不可切除食管癌的放射治疗。关于108例病例的回顾性分析]
Bull Cancer Radiother. 1990;77(1):69-76.
4
[Radiotherapy treatment of esophageal carcinoma--analysis of 5-year survival].[食管癌的放射治疗——5年生存率分析]
Gan No Rinsho. 1984 Jul;30(8):885-90.
5
[Radiotherapy of esophageal cancer: the local effect and prognosis].[食管癌的放射治疗:局部疗效与预后]
Gan No Rinsho. 1989 Sep;35(10):1105-8.
6
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.同步放化疗治疗II-III期食管癌患者局部区域控制中的剂量反应关系。
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):656-64. doi: 10.1016/j.ijrobp.2004.06.022.
7
[Prognosis of 5-year survivors of esophageal cancer treated with radiation and chemotherapy].[接受放疗和化疗的食管癌5年生存者的预后]
Gan No Rinsho. 1987 Apr;33(4):361-4.
8
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.食管癌放化疗的选择性剂量递增:强化治疗的作用
Semin Oncol. 2004 Dec;31(6 Suppl 18):13-9. doi: 10.1053/j.seminoncol.2004.12.006.
9
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].[非转移性食管癌的根治性治疗:同步放化疗与高剂量率腔内近距离放疗增敏]
Gastroenterol Clin Biol. 1999 Oct;23(10):1048-54.
10
[The prognostic significance of esophageal carcinoma based on various irradiation methods].[基于不同照射方法的食管癌的预后意义]
Gan No Rinsho. 1989 Jan;35(1):25-9.